​

Ovid Therapeutics (OVID) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Ovid Therapeutics Revenue Highlights

Latest Revenue (Y)

$7.25M

Latest Revenue (Q)

$132.00K

Main Segment (Y)

Reportable Segment

Ovid Therapeutics Revenue by Period

Ovid Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$7.25M1181.27%
2024-12-31$566.00K44.39%
2023-12-31$392.00K-73.91%
2022-12-31$1.50M-99.28%
2021-12-31$208.38M1551.57%
2020-12-31$12.62M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31--

Ovid Therapeutics generated $7.25M in revenue during NA 2025, up 1181.27% compared to the previous quarter, and up 57.48% compared to the same period a year ago.

Ovid Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30$132.00K-97.90%
2025-06-30$6.27M4724.62%
2025-03-31$130.00K71.05%
2024-12-31$76.00K-56.07%
2024-09-30$173.00K2.37%
2024-06-30$169.00K14.19%
2024-03-31$148.00K4.23%
2023-12-31$142.00K30.28%
2023-09-30$109.00K45.33%
2023-06-30$75.00K13.64%
2023-03-31$66.00K42.61%
2022-12-31$46.28K316.86%
2022-09-30$11.10K100.00%
2022-06-30--100.00%
2022-03-31$1.45M-100.35%
2021-12-31$-416.35M100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$208.38M3553.80%
2020-12-31$5.70M-17.51%
2020-09-30$6.91M100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--

Ovid Therapeutics generated $132.00K in revenue during Q3 2025, up -97.90% compared to the previous quarter, and up 78.11% compared to the same period a year ago.

Ovid Therapeutics Revenue Breakdown

Ovid Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 22Dec 21
Reportable Segment$7.25M--
License-$1.50M$12.38M
Related Party--$196.00M

Ovid Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 22Sep 22Mar 22Mar 21
Reportable Segment$718.00K$132.00K$6.27M$130.00K----
License----$46.28K$11.10K$1.45M$12.38M
Related Party-------$196.00M

Ovid Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Ovid Therapeutics Revenue Breakdown by Country

Quarterly Revenue by Country

CountrySep 22Mar 22Mar 21
Related Party--$196.00M
License$11.10K$1.45M$12.38M

Ovid Therapeutics's latest quarterly revenue breakdown by geography, as of Sep 22: License (100.00%).

Ovid Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MGNXMacroGenics$149.50M$22.24M
WHWKWhitehawk Therapeutics$25.98M$7.24M
OVIDOvid Therapeutics$7.25M$132.00K
ORMPOramed Pharmaceuticals$2.00M-
STTKShattuck Labs$1.00M-
CLNNClene$200.00K$15.00K
IFRXInflaRx$61.80K$36.25K
CNTXContext Therapeutics--
CNTBConnect Biopharma-$48.00K
KLRSKalaris Therapeutics--
IMAImageneBio--

OVID Revenue FAQ

What is Ovid Therapeutics’s yearly revenue?

Ovid Therapeutics's yearly revenue for 2025 was $7.25M, representing an increase of 1181.27% compared to 2024. The company's yearly revenue for 2024 was $566K, representing an increase of 44.39% compared to 2023. OVID's yearly revenue for 2023 was $392K, representing a decrease of -73.91% compared to 2022.

What is Ovid Therapeutics’s quarterly revenue?

Ovid Therapeutics's quarterly revenue for Q3 2025 was $132K, a -97.90% decrease from the previous quarter (Q2 2025), and a -23.70% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $6.27M, a 4724.62% increase from the previous quarter (Q1 2025), and a 3611.24% increase year-over-year (Q2 2024). OVID's quarterly revenue for Q1 2025 was $130K, a 71.05% increase from the previous quarter (Q4 2024), and a -12.16% decrease year-over-year (Q1 2024).

What is Ovid Therapeutics’s revenue growth rate?

Ovid Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 1750.00%, and for the last 5 years (2021-2025) was -96.52%.

What are Ovid Therapeutics’s revenue streams?

Ovid Therapeutics's revenue streams in c 25 are Reportable Segment

What is Ovid Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Ovid Therapeutics was Reportable Segment. This segment made a revenue of $7.25M, representing 100.00% of the company's total revenue.